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Introduction 
Though lithium-induced neurotoxic-
ity usually occurs when serum lithium ex-
ceeds 2.0 mEq/1, reports and reviews 
document its occurence with serum lithium 
within the therapeutic range (Strayhorn 
and Nash 1977; Hansen and Amidsen 
1978; Speirs and Hirsch 1978; West and 
Meltzer 1979). Neurotoxicity has even 
been described with serum lithium bet-
ween 0.4 and 0.5 mEq/l (Hansen and 
Amidsen 1978). Many hypotheses have 
been suggested to explain this paradoxical 
neurotoxicity. These include: interactions 
with other drugs such as haloperidol and 
diuretics (Strayhorn and Nash 1977), 
diphenylhydantoin (Speirs and Hirsch 
1978) and phenothiazines (Spring 1979); 
tissue retention (Strayhorn and Nash 
1977); seizure diathesis (Strayhorn and 
Nash 1977); high pretoxic global ratings of 
psychotic symptomatology and anxiety 
(West and Meltzer 1979); old age (Van der 
Velde 1971); schizophrenia (Shopsin and 
Gershon 1973); intercurrent medical ill-
ness (Shopsin and Gershon 1973; 
Strayhorn and Nash 1977). 
Persistence of neurological deficits 
after recovery is also known, but not fol-
lowing paradoxical neurotoxicity (Hansen 
and Amidsen 1978; Schou, 1984). Cerebel-
lar deficits are most common, but pyramidal 
signs or cognitive deficits may also occur 
(Schou 1984). 
We present the course and outcome of 
a case of lithium-induced paradoxical 
neurotoxicity, discuss certain unusual fea-
tures, and suggest a hypothesis to explain 
our observations. 
Case Report 
R., a 20 year old female, moderately 
mentally-retarded as per the diagnosis at a 
previous consultation, was brought with a 4 
month history of psychological dysfunction 
fulfilling the criteria for a diagnosis of mania 
on DSM III. Physical examination was nor-
mal. She was started on lithium carbonate, 
300mg thrice daily. Eight days later, no 
abatement in mania was observed, but bilat-
eral, horizontal, fixation nystagmus ap-
peared. No other deficits were present. 
Over the next 4 days, drowsiness, confusion 
and disorientation supervened; manic fea-
tures were no longer seen. Besides nystag-
mus, the following cerebellar signs bilater-
ally appeared: dysdiadochokinesis, im-
paired heel to toe and finger-nose coordina-
tion, and gair ataxia. Bilateral pyramidal 
signs, more marked on the right side, were 
also present: spasticity, exaggerated tendon 
reflexes, ankle and patellar clonus and up-
going plantars. Fundoscopic examiantion 
was normal. 
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Lithium was immediately stopped, 
and R. was extensively investigated. 
Serum lithium was 0.5 mEq/1. Hemogram, 
urinanalysis, liver function tests, CSF 
analysis, ECG, chest and skull X-Rays, 
and CT scan were all normal. EEG re-
vealed slowing of background alpha to 7-8 
Hz., seen diffusely and with bilateral sym-
metry. 
Within 6 days of discontinuing 
lithium, the confusion, cerebellar signs 
and pyramidal signs remitted and the 
manic picture reappeared. Nystagmus, 
however, persisted. R. was administered 
10 mg of haloperidol daily, and was dis-
charged 2 months later, euthymic. Barring 
persistent nystagmus, physical examina-
tion was normal at discharge. 
Discussion 
This case presents several unusual 
features: a) Neurotoxicity developed de-
spite a serum lithium level of just 0.5 mEq/ 
1. Literature describes just two cases 
where such paradoxical neurotoxicity has 
occurred at lower serum lithium levels 
(Hansen and Amidsen 1978); b) Cerebel-
lar signs were present early in the acute 
phase - in fact, were the first neuro-logical 
signs to appear. This contrasts with the ob-
servation of Schou (1984) that the acute 
phase of lithium neurotoxicity is without 
cerebellar symptoms; c) A long-term 
neurological deficit (nystagmus) resulted. 
This conforms with Schou's (1984) obser-
vation that persistent lithium-induced de-
ficits (defined as those present more than 2 
months after acute intoxication) are most 
commonly cerebellar in locus, but is un-
usual in that it occurred at a serum lithium 
level of 0.5 mEq/1. Schou's (1984) exten-
sive review does not describe any case 
where lithium-induced neurotoxicity 
sequelae obtained at serum lithium levels 
below 1.2 mEq/1. 
Cases such as ours where intoxication 
(in the form of confusion with bilateral 
cerebellar and pyramidal signs, the latter 
suggestive of lateralization) occurs at a low 
serum lithium level, present the clinician 
with a diagnostic dilemma. Invariably the 
patient needs to be investigated exten-
sively for possible intracranial pathology, 
and secondary mania has to be kept in 
mind. The diagnosis is established only 
after all investigations draw a blank and 
the clinical picture normalizes with discon-
tinuation of lithium. It has been suggested 
that diffuse slowing of the EEG (as in our 
case) may be of great, perhaps diagnostic, 
significance in such cases (Spring 1979). 
Among the hypotheses proposed to 
explain lithium-induced paradoxical 
neurotoxicity are the following: seizure 
diathesis (Strayhorn and Nash 1977), in-
creased age (Van der Velde 1971) and 
schizophrenia (Shopsin and Gershon 
1973). A commom theme in these is an in-
creased incidence of underlying demonstr-
able cerebral pathology. In this context, 
subclinical cerebral impairment has been 
proposed to be predisposing factor for 
lithium-induced neurotoxicity (Speirs and 
Hirsch 1978; Ghadirian and Lehmann 
1980). Interestingly, a similar hypothesis 
has been proposed for the development of 
lithium-carbamazepine neurotoxicity with 
the levels of both drugs being within the 
therapeutic range (Shukla et al, 1984). 
Cerebral impairment undeniably was pre-
sent in our case, since R. was moderately 
mentally retarded. 
We therefore propose that individuals 
with brain damage may be more vulnera-
ble to lithium-induced neurotoxicity (and 
possibly to the subsequent persistence of 
deficits) even at therapeutic serum lithium 
levels. Lithium should therefore be used 
with caution in such cases. 203  CHJTTRANJAN ANDRADE ET AL. 
References 
GHADIRIAN, A.M. & LEHMANN, H.E. (1980), 
Neurological side effects of lithium, Comprehen-
sive Psychiatry, 21, 327-335. 
HANSEN, H.E. & AMIDSEN, A. (1978), Lithium 
intoxication. Quarterly Journal of Medicine, 47, 
123-144. 
SCHOU, M. (1984), Long-lasting neurological 
sequelae after lithium intoxication, Acta 
Psychiatrica Scandinavia, 70, 594-602. 
SHOPSIN, B. & GERSHON, S. (1973), Pharmacol-
ogy-toxicology of lithium ion. In Lithium: its 
Role in Psychiatric Research and Treatment. 
New York, Plenum Press. 
SHUKLA, S., GOODWIN, CD., LONG, L.E.B. 
& MITTER, M.G. (1984), Lithium-car-
bamazepine neurotoxicity and risk factors, 
American Journal of Psychiatry, 141,1604-1606. 
SPEIRS, J. & HIRSCH, S.R. (1978), Severe lithium 
neurotoxicity with "normal" serum concentra-
tions, British Medical Journal 1, 815-816. 
SPRING, G.K. (1979), EEG observations in con-
firming neurotoxicity (ltr.), American Journal of 
Psychiatry, 136, 1099-1100. 
STRAYHORN, J.M. & NASH, J.L. (1977), Severe 
neurotoxicity despite "therapeutic" serum 
lithium levels, Diseases of the Nervous System, 
38,107-111. 
VAN DER VELDE, CD. (1971), Toxicity of 
lithium carbonate in elderly patients, American 
Journal of Psychiatry, 127,1075-1077. 
WEST, A.P. & MELTZER, H.Y. (1979), Paradox-
ical lithium neurotoxicity: a report of 5 cases 
and a hypothesis about risk for neurotoxicity, 
American Journal of Psychiatry, 136, 963 
-966. 